The updated rules are the industry’s latest attempt to restore public confidence that doctors are prescribing medicines in the patient’s interest. The code still has too many loopholes.Click here to access. What do y'all think?
Monday, January 05, 2009
Editorial in the New York Times on the new pharma rules
Check out the New York Times editorial: "No Mugs, but What About Those Fees?" An excerpt: